Leucine induces cardioprotection in vitro by promoting mitochondrial function via mTOR and Opa-1 signaling
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 31 (10) , 2979-2986
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (19K09353)
This publication has 32 references indexed in Scilit:
- Caveolins: targeting pro-survival signaling in the heart and brainFrontiers in Physiology, 2012
- Cardiac-Specific Overexpression of Caveolin-3 Attenuates Cardiac Hypertrophy and Increases Natriuretic Peptide Expression and SignalingJACC, 2011
- Improving bioscience research reporting: The ARRIVE guidelines for reporting animal researchJournal of Pharmacology and Pharmacotherapeutics, 2010
- Opioid-Induced Preconditioning Is Dependent on Caveolin-3 ExpressionAnesthesia & Analgesia, 2010
- Role of Caveolin-3 and Glucose Transporter-4 in Isoflurane-induced Delayed Cardiac ProtectionAnesthesiology, 2010
- Inducible proteolytic inactivation of OPA1 mediated by the OMA1 protease in mammalian cellsJournal of Cell Biology, 2009
- Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion InjuryPhysiological Reviews, 2008
- Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injuryJournal of Molecular and Cellular Cardiology, 2008
- Reactive oxygen species trigger ischemic and pharmacological postconditioning: In vivo and in vitro characterizationLife Sciences, 2007
- The role of mitochondria in protection of the heart by preconditioningBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2007